Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma	skin squamous cell carcinoma	Recruiting	Phase 2	2026-07-08		NCT06288191

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bristol-Myers Squibb	422
Melanoma Institute Australia	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Melanoma Institute Australia	Wollstonecraft	Australia	19

Clinical trials